{"DataElement":{"publicId":"7124629","version":"1","preferredName":"Normal Tissue Segment CPTAC Biospecimen Identifier","preferredDefinition":"The CPTAC specimen identifier of the normal tissue segment collected for review.  The identifier utilizes the pre-defined CPTAC identifier format.","longName":"7120747v1.0:7121849v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"7120747","version":"1","preferredName":"Normal Tissue Segment Biospecimen","preferredDefinition":"Sufficient total material from each patient, divided to yield a minimum of one aliquot, preferably divided into one to three aliquots of non-neoplastic (\"normal\") adjacent tissue (as feasible) suitable for processing for proteomic and genomic analysis._Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.","longName":"7120745v1.0:3004967v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"7120745","version":"1","preferredName":"Normal Tissue Segment","preferredDefinition":"Sufficient total material from each patient, divided to yield a minimum of one aliquot, preferably divided into one to three aliquots of non-neoplastic (\"normal\") adjacent tissue (as feasible) suitable for processing for proteomic and genomic analysis.","longName":"C162623","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Normal Tissue Sample","conceptCode":"C162623","definition":"Tissue sample with cellular composition and architectural patterns expected for the particular anatomic site in which it belongs. There is no evidence of abnormal cellular infiltrates or tumor mass formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9B7C823A-3ABB-01FE-E053-F662850AC3D6","latestVersionIndicator":"Yes","beginDate":"2020-01-06","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-06","modifiedBy":"ONEDATA","dateModified":"2020-01-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3004967","version":"1","preferredName":"Biospecimen","preferredDefinition":"Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.","longName":"C70699","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biospecimen","conceptCode":"C70699","definition":"Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7E53DD71-5644-E092-E040-BB89AD436E56","latestVersionIndicator":"Yes","beginDate":"2010-01-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-01-29","modifiedBy":"ONEDATA","dateModified":"2010-01-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9B7C823A-3AC9-01FE-E053-F662850AC3D6","latestVersionIndicator":"Yes","beginDate":"2020-01-06","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-06","modifiedBy":"KNABLEJ","dateModified":"2020-02-13","changeDescription":"1/22/20 jk released per CPTAC SME's review of PRAD Path Review CDE set. 1/6/20 jk created for CPTAC Path Review CRF; applicable to all tumor types.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7121849","version":"1","preferredName":"CPTAC Biospecimen Identifier","preferredDefinition":"The CPTAC specimen identifier in the format of [C3Y]-XXXXX- ZZ where Y is either N for NCI or L for Leidos, XXXXX is the case ID/kit id, and ZZ equals the type of specimen.","longName":"7121849v1.0","context":"OCCPR","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7121848","version":"1","preferredName":"Clinical Proteomic Tumor Analysis Consortium Biospecimen Identifier","preferredDefinition":"A national effort to accelerate the understanding of the molecular basis of cancer through the application of large-scale proteome and genome analysis, or proteogenomics.:Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","longName":"C157175:C70699:C25364","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Proteomic Tumor Analysis Consortium","conceptCode":"C157175","definition":"A national effort to accelerate the understanding of the molecular basis of cancer through the application of large-scale proteome and genome analysis, or proteogenomics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Biospecimen","conceptCode":"C70699","definition":"Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Identifier","conceptCode":"C25364","definition":"One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9B7CF101-6165-020A-E053-F662850AF630","latestVersionIndicator":"Yes","beginDate":"2020-01-06","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-06","modifiedBy":"ONEDATA","dateModified":"2020-01-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9B7CF101-6176-020A-E053-F662850AF630","latestVersionIndicator":"Yes","beginDate":"2020-01-06","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-06","modifiedBy":"KNABLEJ","dateModified":"2020-02-13","changeDescription":"1/22/20 jk released per CPTAC SME's review of PRAD Path Review CDE set. 1/6/20 jk created for CPTAC Path Review and Local Path CRFs; applicable to all tumor types.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"7218867","version":"1","longName":"Head and Neck","context":"OCCPR"},{"publicId":"7634287","version":"1","longName":"HNSCC Pathology Review","context":"OCCPR"},{"publicId":"6776734","version":"1","longName":"All Generic CRFs","context":"OCCPR"},{"publicId":"7252486","version":"1","longName":"Slide Creation","context":"OCCPR"},{"publicId":"6601275","version":"1","longName":"Brain","context":"OCCPR"},{"publicId":"6779546","version":"1","longName":"LGG Pathology Review","context":"OCCPR"},{"publicId":"5635361","version":"1","longName":"Bladder","context":"OCCPR"},{"publicId":"6779608","version":"1","longName":"BLCA Pathology Review","context":"OCCPR"},{"publicId":"6570064","version":"1","longName":"Stomach","context":"OCCPR"},{"publicId":"6779568","version":"1","longName":"STAD Pathology Review","context":"OCCPR"},{"publicId":"10000439","version":"1","longName":"Thyroid","context":"OCCPR"},{"publicId":"6779573","version":"1","longName":"THCA Pathology Review","context":"OCCPR"},{"publicId":"6776735","version":"1","longName":"Eye","context":"OCCPR"},{"publicId":"6779576","version":"1","longName":"UVM Pathology Review","context":"OCCPR"},{"publicId":"6570063","version":"1","longName":"Cervix","context":"OCCPR"},{"publicId":"6779611","version":"1","longName":"CESC Pathology Review","context":"OCCPR"},{"publicId":"6776762","version":"1","longName":"Bile duct and Liver","context":"OCCPR"},{"publicId":"6779540","version":"1","longName":"CHOL Pathology Review","context":"OCCPR"},{"publicId":"6779543","version":"1","longName":"LIHC Pathology Review","context":"OCCPR"},{"publicId":"6601282","version":"1","longName":"Esophagus","context":"OCCPR"},{"publicId":"6779555","version":"1","longName":"ESCA Pathology Review","context":"OCCPR"},{"publicId":"5635376","version":"1","longName":"Prostate","context":"OCCPR"},{"publicId":"6779563","version":"1","longName":"PRAD Pathology Review","context":"OCCPR"},{"publicId":"7409064","version":"1","longName":"All Procurement CRFs","context":"OCCPR"},{"publicId":"7409065","version":"1","longName":"Solid Tumor Specimen","context":"OCCPR"},{"publicId":"10000348","version":"1","longName":"Melanoma","context":"OCCPR"},{"publicId":"7639000","version":"1","longName":"CM Pathology Review","context":"OCCPR"}]}],"AlternateNames":[{"name":"OCCPR","type":"USED_BY","context":"OCCPR"}],"ReferenceDocuments":[{"name":"Specimen ID","type":"Preferred Question Text","description":"Specimen ID","url":null,"context":"OCCPR"},{"name":"CPTAC-Tumor-Procurement-1","type":"Alternate Question Text","description":"Normal Tissue Specimen 1 ID","url":null,"context":"OCCPR"},{"name":"CPTAC-Tumor-Procurement-2","type":"Alternate Question Text","description":"Normal Tissue Specimen 2 ID","url":null,"context":"OCCPR"},{"name":"CPTAC-Tumor-Procurement-3","type":"Alternate Question Text","description":"Normal Tissue Specimen 3 ID","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9B94F0F0-4546-1657-E053-F662850A3273","latestVersionIndicator":"Yes","beginDate":"2020-01-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-07","modifiedBy":"KNABLEJ","dateModified":"2021-08-17","changeDescription":"8/17/21 jk added CM Path Rpt CSI. 7/12/21 jk added HNSCC Path Rpt CSI. 12/14/20 jk removed Normal tissue procurement CSI; new CDE created per SME review. 10/30/20 jk added Normal Tissue CSI. 9/23/20 jk revised LN te remove redundant biospecimen term.  8/27/20 jk 7/23/20 jk added Procurement CSI, AQT.  4/17/20 jk def mod per SME review to support Slide Creation CRF.  1/22/20 jk released per CPTAC SME's review of PRAD Path Review CDE set. 1/7/20 jk created for CPTAC Path Review CRFs; applicable to all tumor types.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}